In contrast, another study reported no relationship between DYRK2 expression and any clinical factors using immunohistochemistry; however, strong DYRK2 expression was detected in the cytoplasm of lung adenocarcinoma (LADCs) cells [49]. Here, DYRK2 is linked to lung adenocarcinoma.